Tumor-Associated Macrophages in Hepatocellular Carcinoma:Friend or Foe?
- Author:
Dexi ZHOU
1
;
Jiajie LUAN
;
Cheng HUANG
;
Jun LI
Author Information
- Publication Type:Review Article
- From:Gut and Liver 2021;15(4):500-516
- CountryRepublic of Korea
- Language:English
- Abstract: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide, and it has diverse etiologies with multiple mechanisms. The diagnosis of HCC typically occurs at advanced stages when there are limited therapeutic options. Hepatocarcinogenesis is considered a multistep process, and hepatic macrophages play a critical role in the inflammatory process leading to HCC. Emerging evidence has shown that tumor-associated macrophages (TAMs) are crucial components defining the HCC immune microenvironment and represent an appealing option for disrupting the formation and development of HCC. In this review, we summarize the current knowledge of the polarization and function of TAMs in the pathogenesis of HCC, as well as the mechanisms underlying TAM-related anti-HCC therapies. Eventually, novel insights into these important aspects of TAMs and their roles in the HCC microenvironment might lead to promising TAM-focused therapeutic strategies for HCC.
